Sudarshan Pharma Industries Ltd

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and pursuant to the approval of the members obtained at the Extra-ordinary General Meeting held on 30th September 2024 by means of Special Resolution and approval of the members obtained by way of Postal Ballot dated 3rd November 2024 by means of ordinary resolution and In-Principal Approval obtained from BSE Limited the Board of Directors of the Company have at its meeting held on 18th December 2024 at 3.00 p.m. and concluded at 6.15 p.m. has inter-alia considered and approved the allotment of 900000 convertible warrants of Rs.10/- each at a price of Rs.169.83 aggregating to Rs.152847000/- on preferential basis to the persons belonging to Promoter Category.